Veradigm Inc. MDRX is well-poised for growth in the coming quarters, courtesy of its strategic alliances over the past few months. The optimism, led by a solid third-quarter 2022 performance and its ...

Veradigm Inc. Quarterly stock financials by MarketWatch. View the latest MDRX financial statements, income statements and financial ratios.

Veradigm ( ($MDRX) ) has issued an update. On December 31, 2025, healthcare technology firm Veradigm Inc. extended Interim Chief Financial Officer ...

Investors in Veradigm Inc (Symbol: MDRX) saw new options become available this week, for the January 2024 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDRX ...

Investors in Veradigm Inc (Symbol: MDRX) saw new options become available this week, for the July 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDRX ...

Veradigm Inc. MDRX shares ended the last trading session 5% higher at $18.70. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** Utah-based firearms manufacturer, ...

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At ...

The most recent short interest data was recently released by the NASDAQ for the 08/30/2013 settlement date, and Allscripts Healthcare Solutions, Inc. (NASD: MDRX) is one of the most shorted stocks of ...

Veradigm Inc. Annual cash flow by MarketWatch. View MDRX net cash flow, operating cash flow, operating expenses and cash dividends.